See Recent Shionogi-Sponsored Congress Presentations

Congresses

As part of our commitment to addressing unmet medical needs, Shionogi continues to investigate approved products and pipeline compounds. Shionogi presents its research at major congress events globally.

The content contained herein is for your information only. No reproduction, alteration, or distribution of this information is permitted. Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.

Select a congress event or filter to view available congress presentations.

  • All
  • AMCP
  • CHEST
  • CROI
  • ECCMID
  • ESCMID
  • ESWI
  • IAS
  • IDWeek
  • isirv-AVG
  • ISSX
  • NACFC
  • PAGE
  • SCCM
  • All
  • 2025
  • 2024
  • 2023
  • All
  • Gram-negative infection
  • COVID-19
  • All
  • Cefiderocol
  • Ensitrelvir
  • Xeruborbactam
  • S-892216
  • All
  • Oral presentation
  • Poster presentation

You Are Viewing Presentations

ESCMID 2024
Cefiderocol

Real-world experience of cefiderocol in bone and joint infections from the PROVE (retrospective cefiderocol chart review) study

View/Download Presentation
ESCMID 2024
Cefiderocol

Real-world experience of cefiderocol in France from the PROVE (retrospective cefiderocol chart review) study

View/Download Presentation
CHEST 2023
Cefiderocol

Real-world experience of cefiderocol in treating hospital-acquired pneumonia due to Gram-negative pathogens in the us hospitals from January 2020 to June 2022

View/Download Presentation
IDWeek 2024
Ensitrelvir

Real-world safety and effectiveness of ensitrelvir in COVID-19 patients with risk factor: a post-marketing surveillance in Japan

View/Download Presentation
IDWeek 2023
Cefiderocol

Real-World use of cefiderocol treating non-COVID patients with confirmed Gram-negative infections in US hospitals during January 2020 - June 2022

View/Download Presentation
IDWeek 2023
Ensitrelvir

Safety and effectiveness of ensitrelvir for the treatment of COVID-19 in Japanese clinical practice: A post-marketing surveillance (interim analysis)

View/Download Presentation

You Are Viewing Congress Locations